Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bao Yuan Capsule (BYC) is a patented Traditional Chinese Medicine (TCM) formula originally developed by the Chinese PLA General Hospital (301 Hospital) and commercialized by Beijing Red Wall Biological Engineering. It is composed of four key herbal ingredients: *Cordyceps sinensis*, *Astragalus membranaceus*, *Panax ginseng*, and *Panax notoginseng*. Traditionally used for health promotion, anti-aging, and immunomodulation, recent research from the University of Hong Kong has demonstrated its potential neuroprotective and neurogenic effects. In preclinical models of ischemic stroke, Bao Yuan Capsule has been shown to promote neurogenesis and neurological functional recovery by improving mitochondrial function, reducing oxidative stress, and activating the PI3K/Akt/beta-catenin signaling pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bao Yuan Capsule.